Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2003-08-01
|
| Series: | Swiss Medical Weekly |
| Subjects: | |
| Online Access: | https://www.smw.ch/index.php/smw/article/view/299 |
| _version_ | 1798003504222044160 |
|---|---|
| author | BSE August-Jörg R Hermann M Weitz E Renner |
| author_facet | BSE August-Jörg R Hermann M Weitz E Renner |
| author_sort | BSE August-Jörg |
| collection | DOAJ |
| first_indexed | 2024-04-11T12:09:40Z |
| format | Article |
| id | doaj.art-879105496fe043e0b805026ccddc5e55 |
| institution | Directory Open Access Journal |
| issn | 1424-3997 |
| language | English |
| last_indexed | 2024-04-11T12:09:40Z |
| publishDate | 2003-08-01 |
| publisher | SMW supporting association (Trägerverein Swiss Medical Weekly SMW) |
| record_format | Article |
| series | Swiss Medical Weekly |
| spelling | doaj.art-879105496fe043e0b805026ccddc5e552022-12-22T04:24:39ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972003-08-01133333410.4414/smw.2003.10300Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis cBSE August-JörgR HermannM WeitzE Rennerhttps://www.smw.ch/index.php/smw/article/view/299SASLRibavirinInterferonalphacombination therapyRelapseHepatitis C |
| spellingShingle | BSE August-Jörg R Hermann M Weitz E Renner Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c Swiss Medical Weekly SASL Ribavirin Interferonalpha combination therapy Relapse Hepatitis C |
| title | Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c |
| title_full | Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c |
| title_fullStr | Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c |
| title_full_unstemmed | Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c |
| title_short | Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c |
| title_sort | twenty four vs fourty eight weeks of re therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis c |
| topic | SASL Ribavirin Interferonalpha combination therapy Relapse Hepatitis C |
| url | https://www.smw.ch/index.php/smw/article/view/299 |
| work_keys_str_mv | AT bseaugustjorg twentyfourvsfourtyeightweeksofretherapywithinterferonalpha2bandribavirinininterferonalphamonotherapyrelapserswithchronichepatitisc AT rhermann twentyfourvsfourtyeightweeksofretherapywithinterferonalpha2bandribavirinininterferonalphamonotherapyrelapserswithchronichepatitisc AT mweitz twentyfourvsfourtyeightweeksofretherapywithinterferonalpha2bandribavirinininterferonalphamonotherapyrelapserswithchronichepatitisc AT erenner twentyfourvsfourtyeightweeksofretherapywithinterferonalpha2bandribavirinininterferonalphamonotherapyrelapserswithchronichepatitisc |